Safetussin Max Strength Multi-Symptom blister packs recalled for non-child-resistant packaging
Kramer Laboratories recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu blister packs due to packaging that fails to resist child access. Tablets can be pushed through the foil, posing a poisoning risk to young children.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Scores High (3) because it involves a risk-of-harm product (acetaminophen accessible to young children) where no injuries have been reported. Per the rubric, when source text explicitly states no illnesses or injuries and the hazard is theoretical, the score is at most 3.
Plain-English summary
Kramer Laboratories is recalling approximately 14,250 units of Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. The product is labeled with "Safetussin," "Multi-Symptom," and "Cough, Cold & Flu" and was sold in blue, orange, and red cardboard boxes.
The recall stems from a violation of the Poison Prevention Packaging Act. The blister pack packaging is not child-resistant, as it allows tablets to be pushed through the foil. Acetaminophen, a key ingredient in this product, is required by federal law to be in child-resistant packaging.
The affected products were distributed nationwide through HEB, Harris-Teeter, and other regional grocery stores and independently owned pharmacies from July 2024 through March 2025. They were sold for approximately $11 per package.
Consumers should immediately secure the product out of the sight and reach of children. Contact Kramer Laboratories at 800-824-4894 (Monday through Friday, 8 a.m. to 5 p.m. ET), by email at [email protected], or visit https://safetussin.com/recall for information on return or disposal. The company is offering a full refund. While the recall applies specifically to the packaging, consumers should dispose of both the package and the product inside.
The recalled product
- Product
- Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
- Hazard
- child-poisoning
- non-child-resistant-packaging
- Affected units
- 14,250
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27